Contract research organization (CRO) PPD has expanded its early development research services by adding significant neuroscience and ethno-bridging expertise, broadening its capabilities to offer increased access to patients and special populations at PPD-owned clinical research units (CRUs). An important move as research sponsors—from government funders to commercial sponsors—seek to diversify research participants with the move from volume to precision-driven, value-based research. In this case, they offer specialized services for Japanese ethnic study requirements. Moreover, with growing CNS pipelines, PPD seeks to accommodate more Phase I CNS patient-centric studies.
Early Development Capability in Neurology
PPD has added a 52-bed CRU in Orlando, Florida. The recently acquired unit has a strong track record of recruiting and conducting early phase trials in multiple neurological indications, such as Alzheimer’s disease, which impacts aging populations. The Orlando CRU has completed over 50 Phase I studies in AD and other central nervous system/neurodegenerative therapeutic areas. The Phase I unit consists of individual bedrooms for special patient populations, such as AD...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).